Ticker

No recent analyst price targets found for TMV.

Latest News for TMV

TMV: An Effective Interest Rate Hedge, And Leveraged ETF Watchlist.

The Direxion Daily 20+ Year Treasury Bear 3X ETF offers -3X daily leverage on long-term Treasuries, making it a popular trading and hedging instrument. TMV's long-term drift is historically positive, benefiting from trending rate environments, but it can suffer decay during sideways markets due to beta-slippage. Since January 2022, TMV has gained 230.8% as rates surged, demonstrating its effectiveness as an interest…

Seeking Alpha • Sep 4, 2026
Weave Bio Expands Strategic Advisory Board with Two Former FDA Leaders

SAN FRANCISCO--(BUSINESS WIRE)---- $TMV #AI--Weave Bio, a leader in AI-native regulatory automation for drug development, today announced the expansion of its Strategic Advisory Board (SAB) with the appointment of two former U.S. Food and Drug Administration leaders, Tala Fakhouri, Ph.D., M.P.H. chief AI and regulatory strategy officer at Parexel, and Sean Khozin, M.D., M.P.H., chief executive officer of the CEO…

Business Wire • Jul 16, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for TMV.

No Senate trades found for TMV.

No House trades found for TMV.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top